Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity.

Author: Xiu-Juan LI ¹ ; Xiao-Peng YANG ² ; Shuang SUN ³ ; Xiao-Bei LYU ¹ ; Heng JIA ¹
Author Information

1. Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
2. Department of Medical Equipment, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
3. Department of Ophthalmology, Children's Hospital of Zhengzhou, Zhengzhou, Henan 450052, China.
Publication Type:Journal Article
MeSH: Angiogenesis Inhibitors; administration & dosage; therapeutic use; Female; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Intravitreal Injections; methods; Ranibizumab; administration & dosage; therapeutic use; Retinopathy of Prematurity; drug therapy; surgery; Retrospective Studies
From: Chinese Medical Journal 2016;129(23):2879-2881
CountryChina
Language:English